现代背景下霍奇金淋巴瘤的诊断
本文综述霍奇金淋巴瘤各亚型的诊断特征,强调肿瘤细胞与免疫微环境对准确诊断的关键作用,并讨论分子改变对靶向治疗进展的推动;同时介绍易混淆的类似淋巴增殖性疾病的鉴别要点。
要点
- 霍奇金淋巴瘤所有类型均被认为起源于B细胞,多数源于生发中心。
- 肿瘤细胞特征与免疫环境性质对准确诊断均至关重要。
- 需鉴别其他可形成类似炎症微环境、模仿霍奇金淋巴瘤的淋巴增殖性疾病。
核心结论
- 霍奇金淋巴瘤是包含多个实体的淋巴瘤家族,所有类型现被认为起源于B细胞,多数源于生发中心。
- 肿瘤微环境的重大贡献是统一主题之一,肿瘤细胞与免疫环境性质对准确诊断均关键。
- 理解肿瘤细胞及其微环境的分子改变已推动针对肿瘤和反应性成分的治疗进展。
研究设计与样本
- 本文为综述,提供各亚型诊断特征的更新,并纳入与预后评估及潜在治疗靶点探索相关的额外信息。
主要发现
- 霍奇金淋巴瘤所有类型现被认为起源于B细胞,多数源于生发中心。
- 肿瘤细胞特征与免疫环境性质对准确诊断均至关重要。
- 其他疾病可形成类似炎症微环境,导致模仿霍奇金淋巴瘤的淋巴增殖。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Hodgkin lymphomas are a family of unique lymphoma subtypes, in which the nature of the neoplastic cell was enigmatic for many years. Much of the mystery has been solved, with all forms now considered to be of B-cell origin, in most cases of germinal centre derivation. Today we recognize Hodgkin lymphoma as an eponym that encompasses multiple entities. One of the unifying themes is the major contribution from the tumour microenvironment. Both the character of the neoplastic cells and the nature of the immune environment are critical to accurate diagnosis. Moreover, an understanding of the molecular alterations that characterize both the neoplastic cells and their microenvironment have led to therapeutic advances, targeting both neoplastic and reactive components. Other conditions may foster a similar inflammatory milieu and lead to lymphoproliferations that mimic the Hodgkin lymphomas. In this review we provide an update on the diagnostic features of the various subtypes and include additional information relevant for prognostic evaluation and investigation of potential therapeutic targets. Additionally, we also discuss those conditions that often cause confusion in diagnosis and need to be distinguished from the Hodgkin lymphomas.
引用
- Wang HW, Balakrishna JP, Pittaluga S, et al. Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol. 2018. PMID: 30407610. doi:10.1111/bjh.15614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。